What do studies and labels say about caffeine anhydrous dosage?
| Product | Strength | Label direction |
|---|---|---|
| Stay Awake (US over-the-counter) | 200 mg tablets1 | Adults and children 12 years of age and over: 1 tablet not more often than every 3 to 4 hours1 |
| Alert Aid (US over-the-counter) | 200 mg tablets2 | Adults and children 12 years and over: 1 tablet not more often than every 3 to 4 hours2 |
Tablet strengths and label directions
The table is set at the top of the page
No capsule strength or powder pack size from a label appears in the sources read.
How much is too much a day?
The FDA has cited 400 mg a day as an amount not generally associated with negative effects for most adults, and adds that there is wide variation in both how sensitive people are to the effects of caffeine and how fast they eliminate it from the body.3 The FDA estimates toxic effects such as seizures can be seen with rapid consumption of around 1,200 mg.3
The FDA says pure and highly concentrated caffeine products are often marketed in bulk packaging with up to thousands of servings per container, and the difference between a safe and a toxic amount in these products is very small.4 The FDA adds that, for many of these products, volume measures such as teaspoons are not precise enough to calculate how many milligrams of caffeine are in the recommended serving size.4
What doses did trials use?
| Trial | Dose and schedule | People | Length |
|---|---|---|---|
| Trexler et al. | 300 mg caffeine anhydrous in a drink, 303 mg caffeine as coffee, or placebo, 30 minutes before testing | Fifty-six resistance-trained males enrolled, fifty-four completed | Single dose, two visits at least 48 hours apart5 |
| Kaplan et al., 1997 | 250 mg, 500 mg or placebo, single oral doses | Twelve healthy volunteers | Single-dose crossover6 |
| Watson et al., 2002 | 200 mg caffeine or placebo twice daily, then a caffeine challenge | Twelve healthy volunteers | 1 week, crossover7 |
| Lara et al. | 3 mg/kg/day caffeine in capsules or placebo, crossover | Eleven healthy active participants | 20 consecutive days per treatment8 |
| Drake et al., 2013 | 400 mg in pill form at 6, 3 or 0 hours before habitual bedtime, placebo at the other times | Healthy normal sleepers | Four nights per person, crossover9 |
| Konidari et al. (CrossFit trial) | 7.1 ± 0.7 mg/kg anhydrous caffeine (200 mg tablets) or placebo, 60 minutes before a session | Twelve healthy men | One dose per session, crossover with washout of at least seven days10 |
| NCT03694886 (Univ. of Colorado) | 90 mg caffeine anhydrous in 8 ounces of water, or none (no results posted) | 120 participants in four parallel groups | Single dose, phase 411 |
Trexler et al. gave a flat 300 mg (3–5 mg/kg) to people of 60 to 100 kg; leg press one-rep max improved more with coffee than with caffeine anhydrous, and neither improved strength more than placebo, while both attenuated sprint power reductions to a similar degree.5 In Konidari et al., a crossover trial of twelve healthy men, at least one side effect was reported by 67% of volunteers after caffeine and 25% after placebo.10
Does tolerance develop, and are there cycles?
In Lara et al., eleven healthy active participants took 3 mg/kg/day for 20 consecutive days; compared with placebo, peak cycling power in the incremental test rose by ~4.0 ±1.3%, and the summary says it did so for the first 15 days of ingestion; the authors say the results suggest progressive tolerance.8 Watson et al. (2002) gave twelve healthy volunteers 200 mg caffeine or placebo twice daily for 1 week; the authors conclude that tolerance is incomplete with respect to both peripheral or central effects of caffeine, and that tolerance was not demonstrated in performance or in improvements in positive aspects of mood.7 None of the trials read tests an on/off cycling schedule.
Mixing a powder in a drink
No label or leaflet found says which water, or how much, to mix with caffeine anhydrous powder. Trexler et al. mixed 300 mg caffeine anhydrous powder with noncaloric flavouring and 350 mL of water.5 No label or trial read gives an mg/mL concentration or U-100 syringe use for caffeine anhydrous, which is taken by mouth.
Storage
The Stay Awake 200 mg tablet label says to store at room temperature and avoid excessive heat (greater than 100°F) or humidity.1 The Alert Aid 200 mg tablet label says to store at 25°C (77°F), with excursions permitted between 15° and 30°C (59° to 86°F).2
Frequently asked questions
How does timing before bed matter?
The authors of Drake et al. (2013), a crossover trial, state that 400 mg of caffeine taken 0, 3 or even 6 hours prior to bedtime significantly disrupts sleep, and that even at 6 hours caffeine reduced sleep by more than 1 hour.9
What is a safe daily intake for healthy adults?
A 2017 systematic review by Wikoff and colleagues found the evidence generally supports that up to 400 mg caffeine/day in healthy adults is not associated with overt adverse cardiovascular, behavioural, reproductive, developmental, acute or bone effects.12
References
- Spirit Pharmaceuticals (DailyMed). Stay Awake (CAFFEINE 200 MG). 2024. dailymed.nlm.nih.gov
- DailyMed. Good Neighbor Pharmacy 44-226. 2026. dailymed.nlm.nih.gov
- US FDA. Spilling the Beans: How Much Caffeine is Too Much?. fda.gov
- US FDA. Pure and Highly Concentrated Caffeine. fda.gov
- Eur J Sport Sci. Effects of coffee and caffeine anhydrous on strength and sprint performance. 2015. pmc.ncbi.nlm.nih.gov
- PubMed. Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans. 1997. pubmed.ncbi.nlm.nih.gov
- PMC. Central and peripheral effects of sustained caffeine use: tolerance is incomplete. pmc.ncbi.nlm.nih.gov
- PMC. Time course of tolerance to the performance benefits of caffeine. 2019. pmc.ncbi.nlm.nih.gov
- PMC. Caffeine Effects on Sleep Taken 0, 3, or 6 Hours before Going to Bed. pmc.ncbi.nlm.nih.gov
- Nutrients. Effects of an Acute High Dose of Caffeine on Physiological Responses and Performance During a Strength-Focused CrossFit ® Workout: A Randomized, Double-Blind, Crossover Study. 2025. pmc.ncbi.nlm.nih.gov
- ClinicalTrials.gov. NCT03694886: The Effect of Tablet Size on Cognitive Performance Caffeine. 2019. clinicaltrials.gov
- PubMed. Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children. 2017. pubmed.ncbi.nlm.nih.gov